Press Releases

Mar 25, 2026

Avery Klein

Press Releases

Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease

Maze Therapeutics reported promising topline results from its Phase 2 HORIZON trial of MZE829, an oral dual-mechanism APOL1 inhibitor targeting APOL1-mediated kidney disease. Treatment resulted in a 35.6% mean reduction in proteinuria (uACR) at week 12 across a broad AMKD patient population, with enhanced efficacy in FSGS patients (61.8% reduction)…

MAZE

Mar 25, 2026

Leila Farooq

Press Releases

Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a significant board restructuring led by majority stockholders Inscobee Inc. and Apimeds Korea, who removed several directors and appointed new ones, including a new CEO. This followed disagreements over a prior merger with MindWave Innovations, with MindWave disputing the board chang…

APUS

Mar 25, 2026

Leila Farooq

Press Releases

Picard Medical Reports Full Year 2025 Financial Results

Picard Medical, parent company of SynCardia Systems, reported revenue growth of 12.5% in 2025 with total revenue of $4.9 million. Despite an operating loss of $13.3 million, the company improved its operating loss and increased cash reserves significantly following successful equity and debt financing. The SynCardia Total Artificial Heart continues…

PMI

Mar 25, 2026

Sofia Navarro

Press Releases

Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

Tilray Brands, a leading global lifestyle and consumer packaged goods company in cannabis, beverages, and wellness, announced it will release its Q3 fiscal year 2026 financial results before market open on April 1, 2026, followed by a live conference call and webcast.

TLRY

Mar 25, 2026

Jordan Park

Press Releases

C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma

C4 Therapeutics has dosed the first patient in a Phase 1b trial evaluating the combination of their oral IKZF1/3 degrader cemsidomide with elranatamab (ELREXFIO®), an FDA-approved bispecific antibody, in patients with relapsed or refractory multiple myeloma. The trial aims to establish the optimal dose, assess safety, tolerability, and preliminary …

CCCC

Mar 25, 2026

Hana Yamamoto

Press Releases

Lightbridge to Serve on Industry Advisory Board of $6 Million DOE-Funded Project with Penn State

Lightbridge Corporation (Nasdaq: LTBR) has been selected to serve on the Industry Advisory Board for a $6 million Department of Energy-funded nuclear materials research project at Penn State University. The four-year BTN2M2 consortium aims to advance nuclear materials research using cutting-edge micro- and nano-scale techniques, significantly reduc…

LTBR

Mar 25, 2026

Hana Yamamoto

Press Releases

Energous Wireless Power Solutions Reports Fiscal Year 2025 Results

Energous Corporation announced strong fiscal year 2025 results, reporting $5.6 million in revenue — a 633% increase from 2024 — and the lowest quarterly net loss since 2013. The company achieved four consecutive quarters of revenue growth, expanded production capacity in the U.S., and secured a large expansion with a Fortune 10 retailer. Operationa…

WATT

Mar 25, 2026

Avery Klein

Press Releases

Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City

Garrett Motion Inc., a leader in automotive technology, announced its 2026 Technology and Investor Day on May 20, 2026, in New York City. The event will feature presentations and demonstrations on the company's turbo, zero-emission vehicle, and industrial technology portfolios, highlighting its strategic direction, financial priorities, and long-te…

GTX

Mar 25, 2026

Leila Farooq

Press Releases

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development

Beam Therapeutics announced updated clinical data from its ongoing Phase 1/2 trial of BEAM-302, a gene-editing therapy for Alpha-1 Antitrypsin Deficiency (AATD). The therapy showed a well-tolerated safety profile and durable increases in functional AAT protein with significant reduction in mutant Z-AAT after a single dose. Beam selected 60 mg as th…

BEAM

Mar 25, 2026

Hana Yamamoto

Press Releases

Winnebago Industries Reports Second Quarter Fiscal 2026 Results

Winnebago Industries, a leading manufacturer in outdoor recreation products, reported a 6% increase in net revenues to $657.4 million for Q2 Fiscal 2026 and significant profitability improvements, including a 42.1% rise in adjusted earnings per diluted share to $0.27. The company improved operating income by 50.7% to $11.8 million and executed a $1…

WGO

Mar 25, 2026

Nina Shah

Press Releases

Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)

Merck & Co., Inc. announced an agreement to acquire Terns Pharmaceuticals, a clinical-stage oncology company, for approximately $6.7 billion. The acquisition focuses on Terns' lead investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor, TERN-701, which is in Phase 1/2 trials for chronic myeloid leukemia (CML). The deal reflects Merck's…

MRK TERN

Mar 25, 2026

Avery Klein

Press Releases

BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26

Kanzhun Limited, operating as BOSS Zhipin, announced the continuation and expansion of its share repurchase program, having spent nearly RMB450 million in 2026 to buy back shares. The board increased repurchase authorization to US$400 million through August 2027 and committed to allocating at least 50% of adjusted net income annually for dividends …

BZ

Mar 25, 2026

Maya Rios

Press Releases

PDD Holdings Announces Fourth Quarter 2025 and Fiscal Year 2025 Unaudited Financial Results

PDD Holdings Inc., a US-listed e-commerce company on NASDAQ, announced its unaudited financial results for Q4 and the fiscal year 2025. The company reported a 12% revenue increase in Q4 and a 10% increase for the full year, driven by growth in online marketing and transaction services. However, net income declined by about 11%-12% due to higher ope…

PDD

Mar 25, 2026

Maya Rios

Press Releases

NOV Announces Expansion of Subsea Flexible Pipe Manufacturing Capacity to Support Growing Demand

NOV Inc. announced a $200 million investment to roughly double the capacity of its subsea flexible pipe manufacturing facility in Açu, Brazil, over three years. The expansion aims to satisfy strong demand driven by offshore development activity and replacement needs, with capacity currently near full utilization and backlog extending through 2028. …

NOV

Mar 25, 2026

Ajmal Hussain

Press Releases

ADMA Biologics Addresses Misleading Short-Seller Report

ADMA Biologics, a U.S.-based biopharmaceutical company specializing in plasma-derived biologics for immune deficiencies, has publicly addressed a negative short-seller report issued by Culper Research. The company refutes the report's assertions as speculative and false, emphasizing its compliance with regulatory standards and ongoing review of the…

ADMA

Mar 25, 2026

Maya Rios

Press Releases

Amaze Highlights First Quarter 2026 Achievements and Upcoming Priorities in Letter to Shareholders

Amaze Holdings, Inc. issued a shareholder letter highlighting its transition from stabilizing the business in 2025 to accelerating growth in 2026. The company is focusing on expanding its Creator Commerce Flywheel by leveraging proprietary data, enhancing distribution through partnerships like the LA Times Studios integration, and scaling modular i…

AMZE

Mar 25, 2026

Avery Klein

Press Releases

Akamai Launches Brand Guardian to Help Enterprises Combat Automated Fraud

Akamai Technologies has introduced Brand Guardian, an AI-driven solution designed to help enterprises proactively detect and manage brand impersonation and fraudulent digital content. By combining continuous internet monitoring with automated takedowns at 99.99% accuracy, it aims to protect sectors like financial services, retail, and healthcare fr…

AKAM

Mar 25, 2026

Hana Yamamoto

Press Releases

Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026

Comstock Inc. announced that it will participate in a webcast presentation at the Lytham Partners 2026 Industrials & Basic Materials Investor Summit scheduled for April 1, 2026. The company continues to focus on innovative technologies that extract and recycle critical metals from end-of-life photovoltaics, supporting clean energy systems.

LODE

Mar 25, 2026

Hana Yamamoto

Press Releases

Viomi Technology Co., Ltd Reports Second Half and Full Year 2025 Unaudited Financial Results and Announces Special Dividend

Viomi Technology Co., Ltd, a NASDAQ-listed Chinese home water solutions company, announced unaudited financial results for H2 and full-year 2025, showing a 14.6% revenue increase to RMB2.43 billion for the year despite a 25.9% revenue decline in the second half. Net income dipped slightly by 1.9% year-over-year to RMB141.6 million. The company attr…

VIOT

Mar 25, 2026

Derek Hwang

Press Releases

RSA Conference 2026: Varonis CEO Yaki Faitelson to Deliver Keynote on Securing the Agentic AI Revolution

Varonis Systems, Inc. announced that CEO Yaki Faitelson will deliver the keynote speech at RSA Conference 2026 focusing on AI's impact on enterprise security. The company will showcase its new Atlas AI security platform, emphasizing tools to secure AI and data at scale, aiming to help organizations future-proof AI and data security programs.

VRNS

Mar 25, 2026

Nina Shah

Press Releases

VEON Highlights Uklon’s Expansion into Travel, Strengthening its Mobility Ecosystem in Ukraine

VEON Ltd., a Nasdaq-listed digital operator, announced that its subsidiary Uklon, Ukraine’s leading ride-hailing service, has launched a new Travel service within its app. This service allows users to book domestic and international bus tickets, expanding Uklon's offerings beyond urban ride-hailing and delivery into intercity and cross-border mobil…

VEON

Mar 25, 2026

Hana Yamamoto

Press Releases

Auddia Announces LT350 Micro Warehouse Network in Parking Lots for Last Mile Delivery

Auddia Inc. announced the development of the LT350 micro warehouse network, a patented platform transforming parking lots into distributed logistics hubs integrating drones, autonomous electric vehicles, secure package lockers, and AI-driven routing. This platform aims to address last-mile delivery challenges by creating a solar-powered canopy infr…

AUUD

Mar 25, 2026

Sofia Navarro

Press Releases

Kyivstar Subsidiary Uklon Expands Product Ecosystem with Bus Ticket Purchasing

Kyivstar Group's subsidiary Uklon, Ukraine's largest ride-hailing company, has launched a new "Travel" service within its app, enabling users to buy domestic and international bus tickets directly without third-party platforms. This expansion diversifies Uklon's offerings beyond ride-hailing into a broader mobility and travel ecosystem. Kyivstar, l…

KYIV

Mar 25, 2026

Hana Yamamoto

Press Releases

Zhihu Inc. Reports Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

Zhihu Inc. announced its unaudited financial results for Q4 and fiscal year 2025, reporting a decline in total revenues for both the quarter and full year compared to 2024, with a Q4 net loss of RMB210.8 million (US$30.1 million). Despite revenue decreases driven by a strategic refinement of service offerings and membership declines, the company ac…

ZH

Mar 25, 2026

Hana Yamamoto

Press Releases

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

Royal Philips has launched IntraSight Plus, an integrated interventional cardiology platform cleared by the FDA and CE marked for Europe. The system combines diagnostic imaging and physiology tools on a single screen, streamlining workflow, improving precision in treatment planning, and potentially reducing operation times by up to 47%. The launch …

PHG